Alan Abdulla

Alan Abdulla is a Researcher at the Department of Pharmacy within Erasmus MC, part of Erasmus University Rotterdam. His research focuses on pharmacokinetics, antibiotic efficacy, and therapeutic drug monitoring in critical care settings. He has contributed to studies examining antibiotic target attainment in critically ill patients, including those with obesity and those affected by COVID-19.

Key research areas include beta-lactam antibiotics, ciprofloxacin, and ceftriaxone, with emphasis on population pharmacokinetic modeling and dose individualization. His work addresses challenges in achieving optimal antibiotic exposure in complex patient populations to improve clinical outcomes.

Collaborations involve multidisciplinary teams investigating pharmacometric approaches to antimicrobial stewardship and infectious disease management. Recent studies highlight the importance of pharmacokinetic/pharmacodynamic (PK/PD) parameters in predicting treatment success and mortality associations.